Evidence map›Paper›PMID 35134211›Full record

ArticleJournal of the National Cancer Institute2022

Racial and Ethnic Differences in Genomic Profiling of Early Onset Colorectal Cancer.

David M Hein, Weiye Deng, MaryLena Bleile, Syed Ali Kazmi, Brooke Rhead, Francisco M De La Vega, Amy L Jones, Radhika Kainthla, Wen Jiang, Brandi Cantarel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

David M HeinDepartment of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
Weiye DengDepartment of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
MaryLena BleileDepartment of Statistical Science, Southern Methodist University, Dallas, TX, USA.
Syed Ali KazmiDepartment of Medical Oncology, University of Texas Southwestern, Dallas, TX, USA.
Brooke RheadTempus Labs, Inc, Chicago, IL, USA.
Francisco M De La VegaTempus Labs, Inc, Chicago, IL, USA.
Amy L JonesDepartment of Medical Oncology, University of Texas Southwestern, Dallas, TX, USA.
Radhika KainthlaDepartment of Medical Oncology, University of Texas Southwestern, Dallas, TX, USA.
Wen JiangDepartment of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
Brandi CantarelLyda Hill Department of Bioinformatics, University of Texas Southwestern, Dallas, TX, USA.
Nina N SanfordDepartment of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.ORCID 0000-0001-7840-5700
The University of Texas Southwestern Medical Center · USTempus Labs (United States) · USThe University of Texas MD Anderson Cancer Center · USSouthern Methodist University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence and mortality of early onset colorectal cancer (EOCRC) is rising; outcomes appear to differ by race and ethnicity. We aimed to assess differences in mutational landscape and gene expression of EOCRC by racial and ethnic groups (non-Hispanic Asian, non-Hispanic Black, non-Hispanic White, White Hispanic) using data from the American Association for Cancer Research Project GENIE (10.2) and University of Texas Southwestern, the latter enriched in Hispanic patients. All statistical tests were 2-sided. Of 1752 EOCRC patients, non-Hispanic Black patients had higher rates of KRAS mutations (60.9%; P = .001, q = 0.015), and non-Hispanic White and non-Hispanic Black patients had higher rates of APC mutations (77.1% and 76.6% among non-Hispanic White and non-Hispanic Black patients, respectively; P = .001, q = 0.015) via the Fisher exact test with Benjamini-Hochberg correction. Using R packages DESeq2 and clusterProfiler, we found that White Hispanic patients had increased expression of genes involved in oxidative phosphorylation (P < .001, q = 0.025). Genomic profiling has the potential to identify novel diagnostics and influence individualized treatment options to address the currently limited prognosis of EOCRC.

Indexed as

Colorectal NeoplasmsEthnicityBlack or African AmericanBlack PeopleGenomicsHispanic or LatinoHumansUnited States

Identifiers

PMID35134211
PMCPMC9086761
OpenAlexW4210476777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.